Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel as Radiosensitizer for Locally Advanced Cervical Cancer
NCT00452920Phase 2Withdrawn
- Sponsor
- University of Miami
- Start
- Sep 2003
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in Cervical Cancer (CC), sponsored by University of Miami. Planned start Sep 2003; status: withdrawn.
02
Drugs
docetaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00452920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00452920.